Home › Pulmonary Arterial Hypertension › California
Pag-aaral pangklinika para sa Pulmonary Arterial Hypertension sa California
12 pag-aaral para sa Pulmonary Arterial Hypertension ang naghahanap ng mga kalahok sa mga site sa California.
Mga Lungsod sa California
- Mountain View7 pag-aaral
- Los Angeles4 pag-aaral
- Sacramento3 pag-aaral
- Santa Barbara3 pag-aaral
- San Francisco3 pag-aaral
Opisyal na teksto ng pag-aaral (English)
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
- UC Davis - Medial Center ( Site 1064), Sacramento
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07218029A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
- USA012, Los Angeles
- USA008, Santa Barbara
- USA005, Torrance
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07481981An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
- Cedars Sinai, Beverly Hills
- Jeffrey S. Sager, MD Medical Corporation, Santa Barbara
- Lundquist at Harbor UCLA, Torrance
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07365332Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Lucile Packard Children's Hospital, Palo Alto
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 0 hanggang 20 · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT04278404A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- University of California Davis Health, Rancho Cordova
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07175038Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
- Valley Advanced Lung Diseases Institute, Fresno
- Department of Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles
- UC Davis Health Medical Center, Sacramento
- at 1 pa
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT06274801A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
- UC Irvine Medical Center, Orange
- Stanford Medical Center, Stanford
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Hul 21, 2026 · NCT06649110A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial Hypertension
- Stanford University, Stanford
Nagre-recruitPhase 1
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Abr 23, 2026 · NCT06872112Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
- The Regents of the University of California - Los Angeles (UCLA Pediatrics) ( Site 1606), Los Angeles
- Stanford University School of Medicine ( Site 1603), Palo Alto
- UCSF Benioff Children's Hospital San Francisco ( Site 1611), San Francisco
Nagre-recruitPhase 2
Edad 1 hanggang 17 · Lahat ng kasarian · Na-update Abr 20, 2026 · NCT05587712Pulmonary Hypertension Association Registry
- UC Davis Health, Sacramento
- UCSF Medical Center, San Francisco
- UCSF Benioff Children's Hospital, San Francisco
- at 2 pa
Nagre-recruitObservasyonal na pag-aaral
Edad 0 pataas · Lahat ng kasarian · Na-update Nob 14, 2025 · NCT04071327Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- University of California-Los Angeles, Los Angeles
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2025 · NCT04555161Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
- Stanford University Medical Center, Palo Alto
- University California San Francisco, San Francisco
Nagre-recruitObservasyonal na pag-aaral
1 Day – 21 Years · Lahat ng kasarian · Na-update Mar 13, 2025 · NCT02249923Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.